Literature DB >> 2974852

The treatment of a hyperandrogenic and virilizing state in an elderly female with a synthetic LHRH agonist.

J H Parr1, R R Abraham, M Seed, F Short, V Wynn.   

Abstract

A case of hyperandrogenism and virilization is described in an elderly female. She had elevated testosterone levels, but normal DHEAS and 24-h urinary 17-oxosteroid excretion, suggesting an ovarian tumor. Stimulation and suppression tests, and radioisotopic and radiological scans proved unhelpful in the diagnosis although hyperthecosis of the ovary was later suggested by ultrasound. Testosterone and gonadotropin levels fell during therapy with cyproterone acetate and subsequently ethinyl estradiol. Because of side effects encountered on these drugs, she was treated with a synthetic, slow-release preparation of an LHRH agonist, D-TRP-6-LHRH (Decapeptyl), with symptomatic and biochemical improvement. Long term LHRH agonists might be a valuable treatment for hyperandrogenic states in elderly patients.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2974852     DOI: 10.1007/BF03349077

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  25 in total

1.  Postmenopausal virilization due to ovarian stromal hyperthecosis.

Authors:  S S Braithwaite; B Erkman-Balis; T D Avila
Journal:  J Clin Endocrinol Metab       Date:  1978-02       Impact factor: 5.958

2.  Virilizing syndrome associated with an adrenal cortical adenoma secreting predominantly testosterone.

Authors:  D E Schteingart; M C Woodbury; H S Tsao; A K McKenzie
Journal:  Am J Med       Date:  1979-07       Impact factor: 4.965

3.  A gonadotropin-responsive adrenocortical adenoma.

Authors:  J R Givens; R N Andersen; W L Wiser; S A Coleman; S A Fish
Journal:  J Clin Endocrinol Metab       Date:  1974-01       Impact factor: 5.958

4.  Studies of testosterone metabolism in a patient with masculinization due to stromal hyperthecosis.

Authors:  C W Bardin; M B Lipsett; J H Edgcomb; J R Marshall
Journal:  N Engl J Med       Date:  1967-08-24       Impact factor: 91.245

5.  Plasma testosterone stimulation-suppression dynamics in hirsute women.

Authors:  B Ettinger; K Von Werder; G C Thenaers; P H Forsham
Journal:  Am J Med       Date:  1971-08       Impact factor: 4.965

6.  Hyperthecosis syndrome.

Authors:  M Farber; P R Daoust; J Rogers
Journal:  Obstet Gynecol       Date:  1974-07       Impact factor: 7.661

Review 7.  Aspects of androgen-dependent events as studied by antiandrogens.

Authors:  F Neumann; V O Berswordt-Wallrabe R; W Elger; H Steinbeck; J D Hahn; M Kramer
Journal:  Recent Prog Horm Res       Date:  1970

8.  Advanced carcinoma of the prostate: treatment with a gonadotrophin releasing hormone agonist.

Authors:  J M Allen; J P O'Shea; K Mashiter; G Williams; S R Bloom
Journal:  Br Med J (Clin Res Ed)       Date:  1983-05-21

9.  A simple non-chromatographic radioimmunoassay for plasma androstenedione.

Authors:  A B Goodall; A E Rippon; V H James
Journal:  J Steroid Biochem       Date:  1979-08       Impact factor: 4.292

10.  The stimulatory and down-regulatory effects of a gonadotropin-releasing hormone agonist in man.

Authors:  D Heber; S Bhasin; B Steiner; R S Swerdloff
Journal:  J Clin Endocrinol Metab       Date:  1984-06       Impact factor: 5.958

View more
  2 in total

1.  Use of F 18-fluoro-D-glucose-positron emission tomography-computed tomography to localize a hilar cell tumor of the ovary.

Authors:  Desireé M McCarthy-Keith; Micah Hill; John M Norian; Corina Millo; Jeffrey McKeeby; Alicia Y Armstrong
Journal:  Fertil Steril       Date:  2010-04-02       Impact factor: 7.329

2.  A virilizing Leydig cell tumor of the ovary associated with stromal hyperplasia under gonadotropin control.

Authors:  J A Marcondes; M Nery; B B Mendonça; S A Hayashida; H W Halbe; F M Carvalho; B L Wajchenberg
Journal:  J Endocrinol Invest       Date:  1997-12       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.